Other pharmacological treatments for motor complications and dyskinesias
Identifieur interne : 001450 ( Main/Exploration ); précédent : 001449; suivant : 001451Other pharmacological treatments for motor complications and dyskinesias
Auteurs : Cheryl Waters [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-05.
English descriptors
Abstract
Controlling motor complications becomes increasingly difficult with disease progression. The “wearing‐off” phenomenon is the most‐common motor fluctuation. Wearing‐off can be treated by dietary manipulation, shortening the dosing interval, substituting sustained‐release levodopa, adding amantadine, or monoamine oxidase type B inhibitors, and other options, including catechol‐O‐methyltransferase inhibitors and the approved dopamine agonists addressed in another chapter. The rotigotine constant‐delivery system is being developed to treat wearing‐off symptoms. Istradefylline (KW‐6002), an adenosine A2A receptor antagonist, has been studied for wearing‐off and the results will be discussed. The on–off fluctuations can be treated with liquid levodopa and the rescue therapy of injectable apomorphine. Patients may also suffer from dyskinesias. Dyskinesias can be treated with small doses of liquefied levodopa–carbidopa, amantadine, and clozapine, an atypical neuroleptic. © 2005 Movement Disorder Society
Url:
DOI: 10.1002/mds.20462
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Other pharmacological treatments for motor complications and dyskinesias</title><author><name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:30267769EC05F10981667B757C1B5D0B6D435629</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20462</idno><idno type="url">https://api.istex.fr/document/30267769EC05F10981667B757C1B5D0B6D435629/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002D88</idno><idno type="wicri:Area/Main/Curation">002A09</idno><idno type="wicri:Area/Main/Exploration">001450</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Other pharmacological treatments for motor complications and dyskinesias</title><author><name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Movement Disorders, Department of Neurology, Columbia University, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region><settlement type="city">New York</settlement></placeName><orgName type="university">Université Columbia</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-05">2005-05</date><biblScope unit="volume">20</biblScope><biblScope unit="issue">S11</biblScope><biblScope unit="supplement">11</biblScope><biblScope unit="page" from="S38">S38</biblScope><biblScope unit="page" to="S44">S44</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">30267769EC05F10981667B757C1B5D0B6D435629</idno><idno type="DOI">10.1002/mds.20462</idno><idno type="ArticleID">MDS20462</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>dyskinesias</term><term>motor complications</term><term>wearing‐off</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Controlling motor complications becomes increasingly difficult with disease progression. The “wearing‐off” phenomenon is the most‐common motor fluctuation. Wearing‐off can be treated by dietary manipulation, shortening the dosing interval, substituting sustained‐release levodopa, adding amantadine, or monoamine oxidase type B inhibitors, and other options, including catechol‐O‐methyltransferase inhibitors and the approved dopamine agonists addressed in another chapter. The rotigotine constant‐delivery system is being developed to treat wearing‐off symptoms. Istradefylline (KW‐6002), an adenosine A2A receptor antagonist, has been studied for wearing‐off and the results will be discussed. The on–off fluctuations can be treated with liquid levodopa and the rescue therapy of injectable apomorphine. Patients may also suffer from dyskinesias. Dyskinesias can be treated with small doses of liquefied levodopa–carbidopa, amantadine, and clozapine, an atypical neuroleptic. © 2005 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region><settlement><li>New York</li></settlement><orgName><li>Université Columbia</li></orgName></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001450 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001450 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:30267769EC05F10981667B757C1B5D0B6D435629
|texte= Other pharmacological treatments for motor complications and dyskinesias
}}
| This area was generated with Dilib version V0.6.23. |  |